Amplite® Fluorimetric Myeloperoxidase Assay Kit *Red Fluorescence*
Price | |
Catalog Number | |
Unit Size | |
Quantity |
Telephone | 1-800-990-8053 |
Fax | 1-800-609-2943 |
sales@aatbio.com | |
International | See distributors |
Bulk request | Inquire |
Custom size | Inquire |
Shipping | Standard overnight for United States, inquire for international |
Excitation (nm) | 571 |
Emission (nm) | 584 |
H-phrase | H303, H313, H333 |
Hazard symbol | XN |
Intended use | Research Use Only (RUO) |
R-phrase | R20, R21, R22 |
UNSPSC | 12171501 |
Overview | ![]() ![]() |
Excitation (nm) 571 | Emission (nm) 584 |
Platform
Fluorescence microplate reader
Excitation | 540 nm |
Emission | 590 nm |
Cutoff | 570 nm |
Recommended plate | Solid black |
Components
Example protocol
AT A GLANCE
Protocol summary
- MPO standards or test samples (50 µL)
- Add MPO working solution (50 µL)
- Incubate at room temperature for 30 - 60 min
- Read fluorescence intensity at Ex/Em = 540/590 nm (cut off 570 nm)
Important notes
Thaw all the kit components to room temperature before starting the experiment.
PREPARATION OF STOCK SOLUTION
1. Amplite™ Red stock solution (250X):
Add 40 µL of DMSO (Component E) into the vial of Amplite™ Red substrate (Component A). The stock solution should be used promptly. Note: The Amplite™ Red substrate is unstable in the presence of thiols such as dithiothreitol (DTT) and 2-mercaptoethanol. The final concentration of DTT or 2-mercaptoethanol in the reaction should be no higher than 10 µM. The Amplite™ Red substrate is also unstable at high pH (>8.5). Therefore, the reaction should be performed at pH 7 – 8. The provided assay buffer, pH 7.4, is recommended.
2. H2O2 stock solution (500X, 10 mM):
Add 10 µL of 3% H2O2 (0.88M, Component C) into 870 µL of Assay Buffer (Component B). Note: The diluted H2O2 solution is not stable. The unused portion should be discarded.
3. Myeloperoxidase (MPO) standard solution (200 mU/mL):
Add 50 µL of Assay Buffer (Component B) into the vial of Myeloperoxidase Standard (Component D). Note: One vial contains approximately 5 - 10 mU myeloperoxidase.
PREPARATION OF STANDARD SOLUTION
For convenience, use the Serial Dilution Planner: https://www.aatbio.com/tools/serial-dilution/11301
Add 20 µL of 200 mU/mL MPO standard solution into 380 µL of Assay Buffer (Component B) to get 10 mU/mL MPO standard solution (MPO7). Take 10 mU/mL MPO standard solution to perform 1:3 serial dilutions to get remaining serially diluted MPO standards (MPO6 - MPO1).
PREPARATION OF WORKING SOLUTION
Add 20 μL of Amplite™ Red Stock Solution (250X) and 10 μL of H2O2 (500X) into 5 mL of Assay Buffer (Component B) to make a total volume of 5.03 mL MPO working solution. Protect from light.
SAMPLE EXPERIMENTAL PROTOCOL
Table 1. Layout of MPO standards and test samples in a 96-well solid black microplate. MPO= myeloperoxidase standards (MPO1 - MPO7, 0.01 to 10 mU/mL); BL=blank control; TS = test samples.
BL | BL | TS | TS |
MPO1 | MPO1 | ... | ... |
MPO2 | MPO2 | ... | ... |
MPO3 | MPO3 | ||
MPO4 | MPO4 | ||
MPO5 | MPO5 | ||
MPO6 | MPO6 | ||
MPO7 | MPO7 |
Table 2. Reagent composition for each well. Note that high concentration of MPO may cause reduced fluorescence signal due to the over oxidation of Amplite™ Red substrate (to a non-fluorescent product).
Well | Volume | Reagent |
MPO1 - MPO7 | 50 µL | Serial Dilution (0.01 to 10 mU/mL) |
BL | 50 µL | Assay Buffer (Component B) |
TS | 50 µL | test sample |
- Prepare myeloperoxidase standards (MPO), blank controls (BL), and test samples (TS) according to the layout provided in Tables 1 and 2. For a 384-well plate, use 25 µL of reagent per well instead of 50 µL.
- Add 50 µL of MPO working solution to each well of myeloperoxidase standard, blank control, and test samples to make the total MPO assay volume of 100 µL/well. For a 384-well plate, add 25 µL of MPO working solution into each well instead, for a total volume of 50 µL/well.
- Incubate the reaction for 30 to 60 minutes at room temperature, protected from light.
- Monitor the fluorescence intensity with a fluorescence plate reader at Excitation = 530 - 570 nm, Emission = 590 - 600 nm (optimal Ex/Em = 540/590 nm, cut off = 570 nm). Note: The contents of the plate can also be transferred to a white clear bottom plate and read by an absorbance microplate reader at the wavelength of 576 ± 5 nm. The absorption detection has lower sensitivity compared to that of the fluorescence reading.
Images
Citations
Authors: Akentieva, Natalia and Sanina, Natalia and Gizatullin, Artur and Shkondina, Natalia and Andreeva, Anna and Shram, Stanislav and Aldoshin, Sergei
Journal: (2022)
References
Authors: Tan S, Wang G, Peng M, Zhang X, Shen G, Jiang J, Chen F.
Journal: Clin Chim Acta (2009): 216
Authors: Zelzer S, Khoschsorur G, Stettin M, Weihrauch G, Truschnig-Wilders M.
Journal: Clin Chim Acta (2009): 62
Authors: Grulke S, Franck T, Gangl M, Peters F, Salciccia A, Deby-Dupont G, Serteyn D.
Journal: Can J Vet Res (2008): 37
Authors: Fietz S, Bondzio A, Moschos A, Hertsch B, Einspanier R.
Journal: Res Vet Sci (2008): 347
Authors: Sakamoto W, Fujii Y, Kanehira T, Asano K, Izumi H.
Journal: Clin Biochem (2008): 584
Authors: Franck T, Grulke S, Deby-Dupont G, Deby C, Duvivier H, Peters F, Serteyn D.
Journal: J Vet Diagn Invest (2005): 412
Authors: Dypbukt JM, Bishop C, Brooks WM, Thong B, Eriksson H, Kettle AJ.
Journal: Free Radic Biol Med (2005): 1468
Authors: Kapuscinska R, Wysocka J, Niczyporuk W, Ratomski K.
Journal: Wiad Lek (2004): 599
Authors: Yu F, Zhao MH, Zhang YK, Wang HY.
Journal: Zhonghua Nei Ke Za Zhi (2003): 27
Authors: Haqqani AS, S and hu JK, Birnboim HC.
Journal: Anal Biochem (1999): 126
Application notes
Acetylcholinesterase Inhibitory Activity of Pigment Echinochrome A
Ameliorative Effect of Novel Vitamin Formula with Herbal Extracts on Scopolamine-Induced Alzheimer's Disease
An Increase in Plasma Homovanillic Acid with Cocoa Extract Consumption Is Associated with the Alleviation of Depressive Symptoms in Overweight or Obese Adults
Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity